SCHIFF ANDREW N
SEC insider (Form 3/4/5 filer). CIK 0001172252. Director at Monte Rosa Therapeutics, Inc. (GLUE) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in WAYNE, PA.
Companies SCHIFF ANDREW N has filed insider reports for
- Monte Rosa Therapeutics, Inc. (GLUE): Director
- Aclaris Therapeutics, Inc. (ACRS): Director
SCHIFF ANDREW N
CIK: 0001172252
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 11, 2026GLUE
Monte Rosa Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25.8K shares- - Jun 5, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect11.6K shares- - Jun 4, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
42.4K shares- - Jun 4, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
11K shares- - Jun 13, 2025GLUE
Monte Rosa Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30.7K shares- - Jun 6, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect4.8K shares- - Jun 5, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
42.4K shares- - Jun 5, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
11.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  GLUE Monte Rosa Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,800 | - | - | Direct |
| Jun 5, 2026 |  ACRS Aclaris Therapeutics, Inc. | Exercise | 11,580 | - | $0 | Direct |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 42,350 | - | - | Direct |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 10,987 | - | - | Direct |
| Jun 13, 2025 | GLUE Monte Rosa Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,700 | - | - | Direct |
| Jun 6, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 4,793 | - | - | Direct |
| Jun 5, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 42,350 | - | - | Direct |
| Jun 5, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 11,580 | - | - | Direct |
1-8 of 8 transactions